GOLDEN, Colo., July 11, 2000 (PRIMEZONE) -- Isonics Corporation (OTCBB:ISON) (OTCBB:ISONW) announced that its common stock and Class A warrants have been approved for trading on the Nasdaq SmallCap market commencing Thursday, July 13. The trading symbols will remain unchanged.
Isonics' Chairman and CEO James E. Alexander commented, "We are very pleased to have achieved this important objective in the Company's development. Being a Nasdaq-listed company will allow a larger number of individual investors as well as institutions to participate in our further growth."
Isonics is a world leader in isotopically engineered materials and produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics also markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and oxygen-18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. For additional information visit www.isonics.com.
Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 1999 filed with the Securities and Exchange Commission. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.